Tomoko Nanri

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

Tomoko Nanri, Naofumi Matsuno, Toshiro Kawakita et al. · Leukemia · 2005 · 93 citations

Hematological Malignancy, Tumor Biology, Radiation Oncology +11

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

Naofumi Matsuno, Motomi Osato, Naoto Yamashita et al. · Leukemia · 2003 · 56 citations

Hematological Malignancy, Tumor Biology, Flt3 Genes +10

<i><scp>IDH</scp>1</i> and <i><scp>IDH</scp>2</i> mutations confer an adverse effect in patients with acute myeloid leukemia lacking the <i><scp>NPM</scp>1</i> mutation

Shunichiro Yamaguchi, Eisaku Iwanaga, Kenji Tokunaga et al. · European Journal Of Haematology · 2014 · 47 citations

Hematological Malignancy, Chromatin, Transplantation +15

High frequency of <scp><i>IKZF1</i></scp> genetic alterations in adult patients with <scp>B</scp>‐cell acute lymphoblastic leukemia

Kenji Tokunaga, Shunichiro Yamaguchi, Eisaku Iwanaga et al. · European Journal Of Haematology · 2013 · 36 citations

A family harboring a germ‐line N‐terminal C/EBPα mutation and development of acute myeloid leukemia with an additional somatic C‐terminal C/EBPα mutation

Tomoko Nanri, Naokuni Uike, Toshiro Kawakita et al. · Genes Chromosomes and Cancer · 2009 · 32 citations